Although it might seem intuitive at first that cancer cells would benefit greatly from increased rates of protein of synthesis (and in fact they do), in the case of eIF4E this is not really the case, as the levels that elicit oncogenesis are somewhat modest (~2-3 fold) [31] and probably not high enough to alter overall protein abundance. The gene discussed is EIF4E; the disease is cancer.